The need to assess drugs selected from cancer genomic data prior to patient treatment

Personalized Medicine

Volumn 9, Issue 5, 2012, Pages 463-466

  Tolias, Peter ^a  

^a Stevens Institute of Technology   (United States)

Author keywords

3D microfluidic culture; cancer; drug selection and assessment; tumor biopsy; whole genome sequencing

Indexed keywords

TRASTUZUMAB;

CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MODEL; DRUG SCREENING; GENE; GENE SEQUENCE; GENOMICS; HUMAN; MEDICAL DECISION MAKING; MICROFLUIDIC ANALYSIS; PATIENT CARE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; TUMOR BIOPSY;

EID: 84864470424     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.12.51     Document Type: Review

References (14)

1. Sennino B, Ishiguro-Oonuma T, Wei Y et al. Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov. 2(3), 270-287 (2012).
2. Gerlinger M, Rowan AJ, Horswell S et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
3. Wang L, Lawrence MS, Wan Y et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 365(26), 2497-2506 (2011).
4. Stark MS, Woods SL, Gartside MG et al. Frequent somatic mutations in and MAP3K9 in metastatic melanoma identifed by exome sequencing. Nat. Genet. 44, 165-169 (2011).
5. Dancey JE, Bedard PL, Onetto N, Hudson TJ. The genetic basis for cancer treatment decisions. Cell 148, 409-420 (2012).
6. Lipson D, Capelletti M, Yelensky R et al. Identifcation of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat. Med. 18, 382-384 (2012).
7. Perel P, Roberts I, Sena E et al. Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 334(7586), 197 (2007).
8. Hyman AH, Simons K. The new cell biology: beyond HeLa cells. Nature 480, 34 (2011).
9. Chapman S, Liu X, Meyers C, Schlegel R, McBride AA. Human keratinocytes are effciently immortalized by a Rho kinase inhibitor. J. Clin. Invest. 120, 2619-2626 (2010).
10. Liu X, Ory V, Chapman S et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am. J. Pathol. 180(2), 599-607 (2012).
11. Bell E. Why 3D is better than 2D. Nat. Rev. Immunol. 6, 87 (2006).
12. Lee JH, Wang H, Kaplan JB, Lee WY. Microfuidic approach to create three-dimensional tissue models for bioflm-related infection of orthopaedic implants. Tissue Eng. Part C Methods 17, 39-48 (2011).
13. Lee JH, Gu Y, Wang H, Lee WY. Microfuidic 3D bone tissue model for high-throughput evaluation of wound-healing and infection-preventing biomaterials. Biomaterials 33, 999-1006 (2012).
14. Desrochers TM, Shamis Y, Alt-Holland A et al. The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma. Epigenetics 7, 34-46 (2012).